A prospective randomized, double-blind phase 2 study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: Compared with 68Ga-DOTATATE-MedSci.cn - 梅斯（MedSci）

A prospective randomized, double-blind phase 2 study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: Compared with 68Ga-DOTATATE

Zhu, W; Jia, R; Cheng, Y; Zhao, H; Bai, C; Xu, J; Yao, S; Huo, L

JOURNAL OF NEUROENDOCRINOLOGY, 2021; 33 (): 202

科室
- - 订阅+
  - 更多科室
工具
服务